Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 1998 March;50(1) > Minerva Urologica e Nefrologica 1998 March;50(1):45-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA UROLOGICA E NEFROLOGICA

A Journal on Nephrology and Urology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,536


eTOC

 

  XIV CONGRESS OF THE SOCIETA' ITALIANA DI NEFROLOGIA SEZIONE PIEMONTE-VALLE D'AOSTA
(Ivrea, October 5, 1996)


Minerva Urologica e Nefrologica 1998 March;50(1):45-9

language: Italian

Percutaneous transluminal angioplasty of stenosis in arteriovenous fistulas. A 24 month follow-up

Ortensia A. 1, Carosio G. 2, Iberti M. 1, Reale M. 2, Della Volpe M. 1, Taverna G. 2, Veronesi G. 1, Balestrero G. 2

1 Azienda Ospedaliera «S.S. Antonio e Biagio e C. Arrigo» - Alessandria, UOA Nefrologia e Dialisi;
2 Azienda Ospedaliera «S.S. Antonio e Biagio e C. Arrigo» - Alessandria, UOA Cardiologia - Laboratorio di Emodinamica


PDF  


Stenosis is a common cause of the functional loss of vascular shunts used in chronic hemodialysis and percutaneous transluminal angioplasty represents the elective method to correct these anomalies. A total of 42 percutaneous transluminal angioplasties were performed, with a prospective study and follow-up lasting an average of 18 months, in 32 patients with insufficient blood flow of arteriovenous fistula. In over 90% of cases the procedure restored adequate hemodynamic conditions that remained unchanged during follow-up. The authors therefore conclude that percutaneous transluminal angioplasty is an efficacious, easily performed and low-cost method that does not present major complications.

top of page

Publication History

Cite this article as

Corresponding author e-mail